Vertaling van "recognising " (Nederlands → Frans) :

The external services of Unit II inspect manufacturers of medicines (in Belgium and non-EU countries), the wholesalers, the recognised laboratories, the companies recognised on the basis of the royal decree on raw materials used by the pharmacist, the manufacturers of “Active Pharmaceutical Ingredient” (API), blood establishments and cell and tissue banks.
The external services of Unit II inspect manufacturers of medicines (in Belgium and non-EU countries), the wholesalers, the recognised laboratories, the companies recognised on the basis of the royal decree on raw materials used by the pharmacist, the manufacturers of “Active Pharmaceutical Ingredient” (API), blood establishments and cell and tissue banks.

The FAMHP has regulated the distribution sector by ensuring the registration of all distributors and publishing the list of recognised distributors on the FAMHP website.
The FAMHP has regulated the distribution sector by ensuring the registration of all distributors and publishing the list of recognised distributors on the FAMHP website.

To ensure the population the optimal use of the medicines and health products they need, the FAMHP’s team manages, in a recognised, effective and responsible manner, all aspects of this area in consultation with all relevant parties in the health sector and the other national and international authorities.
To ensure the population the optimal use of the medicines and health products they need, the FAMHP’s team manages, in a recognised, effective and responsible manner, all aspects of this area in consultation with all relevant parties in the health sector and the other national and international authorities.

The latter has been designated as having expertise as an “Official Medicines Control Laboratory”, recognised by the FAMHP and the European Directorate for the Quality of Medicines (EDQM), for the monitoring of immunological products for veterinary use prior to marketing authorisation for the Belgian market.
The latter has been designated as having expertise as an “Official Medicines Control Laboratory”, recognised by the FAMHP and the European Directorate for the Quality of Medicines (EDQM), for the monitoring of immunological products for veterinary use prior to marketing authorisation for the Belgian market.

As legally stipulated, the approval procedure is carried out by a recognised institution, Mdeon vzw - asbl.
As legally stipulated, the approval procedure is carried out by a recognised institution, Mdeon vzw - asbl.

Key factor 1 Recognition at national, European and international level ●● Ensuring a strong, recognised identity, internally and externally ●● Implementing the spearheads ●● Ensuring proper coordination at European
Key factor 1 Recognition at national, European and international level ●● Ensuring a strong, recognised identity, internally and externally ●● Implementing the spearheads ●● Ensuring proper coordination at European

It is of crucial importance for anyone working in this area to have sufficient knowledge about it and have the ability to recognise it in order to prevent a suicidal act from being carried out.
Sa connaissance, sa reconnaissance par tout intervenant en la matière est indispensable afin de prévenir le passage à l’acte suicidaire.

Therefore, not including tiredness as one of the symptoms to be looked for during the diagnosis could result in there being a risk of failing to recognise the depression.
Il pourrait donc y avoir un risque de non-reconnaissance de la dépression si la fatigue ne fait pas partie des symptômes recherchés lors du diagnostic.

Even though there now are classifications available that allow the clinical identification of different types of depression, it still remains a fact that it is difficult to recognise one in care practice, especially in primary health care, with there being numerous ways in which this pathology can present itself (masked depression, depression that manifests itself through diffuse and persistent somatic signs…).
S’il existe aujourd’hui des classifications permettant d’identifier les différents types de dépression sur le plan clinique, il n’en reste pas moins vrai qu’en pratique de soin et en particulier en première ligne, des repérages restent difficiles au vu des travestissements de cette pathologie (dépression masquée, dépression se manifestant par des signes somatiques diffus et persistants…).

1974 on the opening, transfer and merger of retail pharmacies Royal decree of 9 July 1984 on the provision of information and advertising relating to medicines Royal decree of 11 January 1993 determining the conditions under which medicines for human use may be supplied in sample form Royal decree of 7 April 1995 on the provision of information and advertising relating to medicines for human use Royal decree of 15 July 1997 on active implantable medical devices, transposing Directive 90/385 EEC (AIMD) Royal decree of 19 December 1997 on the control and analysis of the raw materials used by dispensing chemists Royal decree of 18 March 1999 on medical devices, transposing Directive 93/42/EEC of 14 June 1993 (MDD) Royal decree of 11 July 2003 determining the conditions under which medicines for veterinary use may be supplied in sample form Law of 16 December 2004 modifying the regulations on combating abuses in the promotion of medicines Royal decree of 10 June 2006 establishing the report point referred to in Article 10, § 5, of the law of 25 March 1964 on medicines Royal decree of 23 November 2006 implementing Article 10, § 3, of the law of 25 March 1964 on medicines Royal decree of 25 February 2007 recognising the institutions referred to in Article 10 § 3 of the law of 25 March 1964 on medicines
1974 on the opening, transfer and merger of retail pharmacies Royal decree of 9 July 1984 on the provision of information and advertising relating to medicines Royal decree of 11 January 1993 determining the conditions under which medicines for human use may be supplied in sample form Royal decree of 7 April 1995 on the provision of information and advertising relating to medicines for human use Royal decree of 15 July 1997 on active implantable medical devices, transposing Directive 90/385 EEC (AIMD) Royal decree of 19 December 1997 on the control and analysis of the raw materials used by dispensing chemists Royal decree of 18 March 1999 on medical devices, transposing Directive 93/42/EEC of 14 June 1993 (MDD) Royal decree of 11 July 2003 determining the conditions under which medicines for veterinary use may be supplied in sample form Law of 16 December 2004 modifying the regulations on combating abuses in the promotion of medicines Royal decree of 10 June 2006 establishing the report point referred to in Article 10, § 5, of the law of 25 March 1964 on medicines Royal decree of 23 November 2006 implementing Article 10, § 3, of the law of 25 March 1964 on medicines Royal decree of 25 February 2007 recognising the institutions referred to in Article 10 § 3 of the law of 25 March 1964 on medicines